Bone Biologics Corp (BBLG) stock
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics cash
Cash and short-term investments held at the end of each period.
Bone Biologics's cash was $6.09M at Sep 30, 2026. For fiscal 2025 it was $5.33M, up 60.4% from the year before. Over ten years it grew 7.2% a year on average. The highest annual figure on record is $7.54M in fiscal 2022.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.33M | +60.4% |
| FY2024 | Dec 31, 2024 | $3.33M | +9.9% |
| FY2023 | Dec 31, 2023 | $3.03M | -59.9% |
| FY2022 | Dec 31, 2022 | $7.54M | +12.9% |
| FY2021 | Dec 31, 2021 | $6.68M | +27547.0% |
| FY2019 | Dec 31, 2019 | $24.15K | -97.5% |
| FY2018 | Dec 31, 2018 | $955.37K | +38.4% |
| FY2017 | Dec 31, 2017 | $690.28K | +11.3% |
| FY2016 | Dec 31, 2016 | $620.38K | -44.4% |
| FY2015 | Dec 31, 2015 | $1.12M | -58.1% |
| FY2014 | Dec 31, 2014 | $2.66M | +532179.2% |
| FY2012 | Oct 31, 2012 | $500 | – |
| FY2011 | Oct 31, 2011 | $0 | – |
| FY2010 | Oct 31, 2010 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $6.09M | +0.6% |
| Q2 FY2026 | Jun 30, 2026 | $4.03M | -39.3% |
| Q1 FY2026 | Mar 31, 2026 | $4.53M | +64.9% |
| Q4 FY2025 | Dec 31, 2025 | $5.33M | +60.4% |
| Q3 FY2025 | Sep 30, 2025 | $6.05M | +69.6% |
| Q2 FY2025 | Jun 30, 2025 | $6.64M | +184.7% |
| Q1 FY2025 | Mar 31, 2025 | $2.75M | -14.9% |
| Q4 FY2024 | Dec 31, 2024 | $3.33M | +9.9% |
| Q3 FY2024 | Sep 30, 2024 | $3.57M | -19.9% |
| Q2 FY2024 | Jun 30, 2024 | $2.33M | -66.7% |
| Q1 FY2024 | Mar 31, 2024 | $3.23M | -47.8% |
| Q4 FY2023 | Dec 31, 2023 | $3.03M | -59.9% |
| Q3 FY2023 | Sep 30, 2023 | $4.45M | -18.4% |
| Q2 FY2023 | Jun 30, 2023 | $7.01M | +20.5% |
| Q1 FY2023 | Mar 31, 2023 | $6.19M | -7.3% |
| Q4 FY2022 | Dec 31, 2022 | $7.54M | +223323.6% |
| Q2 FY2022 | Jun 30, 2022 | $5.45M | +122805.0% |
| Q1 FY2022 | Mar 31, 2022 | $5.81M | +8070.6% |
| Q4 FY2021 | Dec 31, 2021 | $6.68M | +271146.0% |
| Q3 FY2021 | Sep 30, 2021 | $3.37K | +38.7% |
| Q2 FY2021 | Jun 30, 2021 | $4.44K | -81.6% |
| Q1 FY2021 | Mar 31, 2021 | $71.17K | -64.7% |
| Q3 FY2020 | Sep 30, 2020 | $2.46K | -98.6% |
| Q1 FY2020 | Mar 31, 2020 | $2.43K | -99.7% |
| Q4 FY2019 | Dec 31, 2019 | $24.15K | -97.5% |
| Q3 FY2019 | Sep 30, 2019 | $201.83K | -91.2% |
| Q2 FY2019 | Jun 30, 2019 | $176.37K | -42.1% |
| Q1 FY2019 | Mar 31, 2019 | $726.41K | +95.6% |
| Q4 FY2018 | Dec 31, 2018 | $955.37K | +38.4% |
| Q3 FY2018 | Sep 30, 2018 | $2.29M | +41.4% |
| Q2 FY2018 | Jun 30, 2018 | $304.56K | -61.1% |
| Q1 FY2018 | Mar 31, 2018 | $371.40K | -77.0% |
| Q4 FY2017 | Dec 31, 2017 | $690.28K | +11.3% |
| Q3 FY2017 | Sep 30, 2017 | $1.62M | +135.7% |
| Q2 FY2017 | Jun 30, 2017 | $783.01K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $620.38K | – |
| Q3 FY2016 | Sep 30, 2016 | $688.23K | – |
See a number that looks wrong?